Process for the preparation of piperazine derivatives
Granted 29 Oct 2013 · 1 office action
Assignee: Gedeon Richter PLC
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Laszlo Czibula, Eva Againe Csongor, Ferenc Sebok, Balint Juhasz +2 · Examiner: Emily Bernhardt · AU 1624 · TC 1600
Life of the application
9 dated eventsAbstract
The invention relates to a process for the preparation of the trans N-{4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-cyclohexyl}-carbamide derivatives of general formula (I) by reacting the compound of formula (III) with a carbamoylchloride of general formula (II) which comprises carrying out the reaction in a mixture of a solvent and concentrated aqueous solution of an alkali hydroxide at a temperature between 40-100° C. in the presence of a phase transfer catalyst, separating the phases and washing the organic layer then removing the solvent and drying the compound of formula (I) obtained until its weight is constant.
Description
9 parts›CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a National Stage application under 35 U.S.C. §371 of International Application No. PCT/HU2009/000110, having an International Filing Date of Dec. 18, 2009, which claims the benefit of priority of HU Application No. P08 00766, having a filing date of Dec. 18, 2008, all of which are incorporated herein in their entirety.
›FIELD OF THE INVENTION
The present invention relates to a new process for the preparation of trans-N-{4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-il]-ethyl}-cyclohexyl}-carbamid derivatives of general formula (I).
›BACKGROUND ART
Compounds of general formula (I) were originally disclosed in the Hungarian Patent Specification No. P0302451 as D3/D2 receptor antagonists. In the P0302451 specification three reaction routes (A, B, C methods) are given for the preparation of compounds of formula (I). According to method “A” an amine derivative is reacted with a (tio)carbamoylchloride compound. In Example 3, Method A of P0302451 the amine is reacted with N,N-dimethyl-carbamoylchloride in anhydrous condition in the presence of triethylamine.
From the industrial point of view drawbacks of the above “A” procedure are the long reaction time (48 hours) and poor yield (65%). Besides, the end product obtained should be purified in an additional recrystallization step.
Our aim was to provide a process lacking the disadvantages of the previous process, i.e. to prepare compounds of formula (I) by an easy-to-working up manner with a shorter reaction time and better yield.
›BRIEF DESCRIPTION OF THE INVENTION
In the course of our experiments we have surprisingly found that when the compound of formula (III)
or a salt and/or a hydrate and/or a solvate thereof is reacted with a carbamoylchloride of general formula (II)
wherein
R 1 and R 2 represent independently C 1-6 alkyl with straight or branched chain optionally substituted with aryl group, or C 2-7 alkenyl group containing 1-3 double bonds, or monocyclic, bicyclic or tricyclic aryl group optionally substituted with one or more C 1-6 alkoxy, trifluoro-C1-6 alkoxy, C1-6 alkoxycarbonyl, C1-6 alkanoyl, aryl, C1-6 alkyltio, halogen or cyano groups, or optionally substituted monocyclic, bicyclic or tricyclic cycloalkyl group, or
R 1 and R 2 together with the adjacent nitrogen atom may form an optionally substituted, saturated or unsaturated, monocyclic or bicyclic heterocyclic ring which may contain further heteroatoms selected from oxygen, nitrogen or sulphur atoms
in the mixture of a solvent and a concentrated aqueous basic solution in the presence of a tetra alkyl-ammonium salt as phase transfer catalyst a compound of general formula (I)
wherein R 1 and R 2 are as described above—is obtained with high yield (above 90%) and short reaction time.
Applying the process according to the invention the working-up process becomes easier: the organic and aqueous phases are separated then after aqueous washing of the organic phase the solvent is removed by distillation and the end product is obtained.
›DETAILED DESCRIPTION OF THE INVENTION
The invention relates to a new process for the preparation of compounds of general formula (I)
wherein
R 1 and R 2 represent independently C 1-6 alkyl with straight or branched chain optionally substituted with aryl group, or C 2-7 alkenyl group containing 1-3 double bonds, or monocyclic, bicyclic or tricyclic aryl group optionally substituted with one or more C 1-6 alkoxy, trifluoro-C1-6 alkoxy, C1-6 alkoxycarbonyl, C1-6 alkanoyl, aryl, C1-6 alkyltio, halogen or cyano groups, or optionally substituted monocyclic, bicyclic or tricyclic cycloalkyl group, or
R 1 and R 2 together with the adjacent nitrogen atom may form an optionally substituted, saturated or unsaturated, monocyclic or bicyclic heterocyclic ring which may contain further heteroatoms selected from oxygen, nitrogen or sulphur atoms.
The advantages of the invention are that the reaction time becomes shorter and the end product can be recovered from the reaction mixture in high purity without further purification, wherein the yield is over 90%.
When R 1 and R 2 represent aryl, the aryl moiety may be a group selected from phenyl, tolyl, naphthyl and phenanthryl groups.
In the procedure according to the invention the compound of formula (III)
or a salt and/or a hydrate and/or a solvate thereof is reacted with a carbamoylchloride of general formula (II)
wherein R 1 and R 2 are described above, in the mixture of a solvent and a concentrated basic solution in the presence of a phase transfer catalyst. In this manner the end product is obtained with shorter reaction time (9-10 hours) and good yield (above 90%).
In a preferred embodiment of the invention the concentrated base is an aqueous solution of an alkali hydroxide, for example NaOH or KOH.
The phase transfer catalyst is a tetraalkylammonium salt, wherein the alkyl moiety may have a C1-6 straight or branched chain. In the choice of a suitable phase transfer catalyst the easy handling can be an important factor. Preferred phase transfer catalysts are the tetra-n-butyl ammonium salts or tetramethylammonium salts, wherein the salt forming anion may be sulphate, chloride or bromide anion.
Suitable solvents, which can be used in the process according to the invention include neutral water immiscible solvents, for example toluene, dichloromethane, chlorobenzene or xylene. In a preferred embodiment of the invention preferably dichloromethane can be used as solvent.
In the working-up step of the process according to the invention the organic and aqueous phases are separated, then after aqueous washing of the organic phase the solvent is removed by distillation and the desired end product is obtained.
›EXAMPLES
The invention is further illustrated by the following non-limiting Examples.
›Examples3
›Example 1
Preparation of trans 4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine
Into a 500 ml four-necked flask 180 ml of dichloromethane, 40 ml of 40% sodium hydroxide, 0.54 g (0.002 mol) of tetra-n-butylammonium bromide and 3.12 g (0.029 mol) of N,N-dimethylcarbamoylchloride are added. The mixture is stirred at a temperature between 20-25° C. for 30 minutes then 6.24 g (0.0145 mol) of trans 4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-cyclohexyl amine dihydrochloride is added. With rigorous stirring the reaction mixture is placed into an oil bath preheated to 45-50° C. and heated to boiling temperature under nitrogen for 10 hours. Then the reaction mixture is cooled to room temperature, the phases are separated and the organic layer is washed with 3×80 ml of water and then 80 ml of 10% sodium chloride solution. The solvent is removed under vacuum; the residue obtained is further dried at maximum 50° C. temperature, until its weight is constant.
Dry weight: 5.7 g (92%).
Melting point: 212-214° C.
›Example 2
Preparation of trans 4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine
Into a 500 ml four-necked flask 180 ml of dichloromethane, 40 ml of 40% sodium hydroxide, 0.54 g (0.002 mol) of tetra-n-butylammonium bromide and 3.12 g (0.029 mol) of N,N-dimethylcarbamoyl chloride are added. The mixture is stirred at a temperature between 20-25° C. for 30 minutes then 6.50 g (0.0145 mol) of trans 4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-cyclohexyl amine dihydrochloride monohydrate is added. With rigorous stirring the reaction mixture is placed into an oil bath preheated to 45-50° C. and heated to boiling temperature under nitrogen for 10 hours. Then the reaction mixture is cooled to room temperature, the phases are separated and the organic layer is washed with 3×80 ml of water and then 80 ml of 10% sodium chloride solution. The solvent is removed under vacuum; the residue obtained is further dried at maximum 50° C. temperature, until its weight is constant.
Dry weight: 5.7 g (92%).
Melting point: 212-214° C.
›Example 3
Preparation of trans N-{4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-cyclohexyl}-morpholine-4-carbonic acid amide
Into a 500 ml four-necked flask 400 ml of dichloromethane, 40 ml of 40% sodium hydroxide, 1.2 g (0.0036 mol) of tetra-n-butylammonium bromide and 11 g (0.074 mol) of N,N-dimethyl carbamoyl chloride are added. The mixture is stirred at a temperature between 20-25° C. for 30 minutes then 15.5 g (0.036 mol) of trans 4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-cyclohexyl amine dihydrochloride is added. With rigorous stirring the reaction mixture is placed into an oil bath preheated to 45-50° C. and heated to boiling temperature under nitrogen for 4 hours. Then the reaction mixture is cooled to room temperature, the phases are separated and the organic layer is washed with 3×80 ml of water and then 150 ml of 10% sodium chloride solution. The solvent is removed under vacuum; the residue obtained is further dried at maximum 50° C. temperature, until its weight is constant.
Dry weight: 15.2 g (90%).
Melting point: 203-205° C.
Claims as granted
7 claimsLog in to read the claims of this application.
Log in to unlockClassifications
4 codes- C07D295/14
- C07D295/135
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this application are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockDocuments
Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.
Log in to unlockChain of title
See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.
Log in to unlock